A detailed history of Schechter Investment Advisors, LLC transactions in Grifols Sa stock. As of the latest transaction made, Schechter Investment Advisors, LLC holds 120,402 shares of GRFS stock, worth $941,543. This represents 0.11% of its overall portfolio holdings.

Number of Shares
120,402
Previous 81,824 47.15%
Holding current value
$941,543
Previous $515,000 107.57%
% of portfolio
0.11%
Previous 0.05%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$6.28 - $9.38 $242,269 - $361,861
38,578 Added 47.15%
120,402 $1.07 Million
Q2 2024

Aug 12, 2024

BUY
$6.27 - $7.7 $437,257 - $536,982
69,738 Added 577.01%
81,824 $515,000
Q1 2024

May 06, 2024

SELL
$5.47 - $11.38 $416,589 - $866,689
-76,159 Reduced 86.3%
12,086 $80,000
Q4 2023

Jan 17, 2024

SELL
$7.71 - $11.56 $70,577 - $105,820
-9,154 Reduced 9.4%
88,245 $1.02 Million
Q3 2023

Nov 06, 2023

SELL
$8.91 - $10.91 $27,522 - $33,700
-3,089 Reduced 3.07%
97,399 $890,000
Q2 2023

Jul 26, 2023

SELL
$7.14 - $9.29 $12,630 - $16,434
-1,769 Reduced 1.73%
100,488 $920,000
Q1 2023

Apr 28, 2023

SELL
$6.65 - $10.69 $9,509 - $15,286
-1,430 Reduced 1.38%
102,257 $753,000
Q4 2022

Feb 13, 2023

BUY
$5.96 - $8.53 $13,737 - $19,661
2,305 Added 2.27%
103,687 $881,000
Q3 2022

Nov 04, 2022

SELL
$5.95 - $14.3 $22,163 - $53,267
-3,725 Reduced 3.54%
101,382 $624,000
Q2 2022

Nov 03, 2022

BUY
$10.6 - $13.28 $1.11 Million - $1.4 Million
105,107 New
105,107 $1.25 Million
Q1 2022

Nov 18, 2022

BUY
$10.37 - $12.73 $83,820 - $102,896
8,083 Added 7.97%
109,465 $1.28 Million
Q4 2021

Dec 27, 2022

SELL
$10.21 - $15.27 $668,499 - $999,803
-65,475 Reduced 64.58%
35,907 $404,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.31B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Schechter Investment Advisors, LLC Portfolio

Follow Schechter Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schechter Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schechter Investment Advisors, LLC with notifications on news.